Concepedia

Jorge Hernando

JH

21

Publications

977

Citations

15

H-Index

2018

Active since

Affiliations

Vall d'Hebron Hospital Universitari(Current)

Hospital Universitario 12 De Octubre

Hospital Universitario Central de Asturias

Institut d'Investigació Biomédica de Bellvitge

The Christie NHS Foundation Trust

Jorge Hernando is an author at Vall d'Hebron Hospital Universitari specializing in medicine, cancer research, and oncology.

ORCID

Top concepts

Publications per year

2018–2025

21

Publications

21

Cabozantinib for radioiodine-refractory differentiated thyroid cancer (COSMIC-311): a randomised, double-blind, placebo-controlled, phase 3 trial

Marcia S. Brose, Bruce Robinson, Steven I. Sherman et al. · The Lancet Oncology · 2021 · 221 citations

, , +12

Fusobacterium nucleatum persistence and risk of recurrence after preoperative treatment in locally advanced rectal cancer

Garazi Serna, Fiorella Ruíz‐Pace, Jorge Hernando et al. · Annals of Oncology · 2020 · 139 citations · Full text

Lenvatinib in Patients With Advanced Grade 1/2 Pancreatic and Gastrointestinal Neuroendocrine Tumors: Results of the Phase II TALENT Trial (GETNE1509)

Jaume Capdevila, Nicola Fazio, Carlos López et al. · Journal of Clinical Oncology · 2021 · 103 citations · Full text

Early evolutionary divergence between papillary and anaplastic thyroid cancers

J. Capdevila, Regina Mayor, Francesco M. Mancuso et al. · Annals of Oncology · 2018 · 72 citations

Hemicolectomy versus appendectomy for patients with appendiceal neuroendocrine tumours 1–2 cm in size: a retrospective, Europe-wide, pooled cohort study

Cédric Nesti, Konstantin Bräutigam, Marta Benavent et al. · The Lancet Oncology · 2023 · 64 citations · Full text

, , +6

Rows per page

1–5 of 21